Ozempic alternatives offer a variety of options for those who want to switch due to side effects, availability, or cost. Below is a breakdown of readily available alternatives, all vetted by our ...

If you are looking for an outstanding free GeoGuessr alternative, look no further than City Guesser. This browser game offers a captivating experience, similar to GeoGuessr, but with a unique twist—it ...

But Lightroom is far from the only photography software for organizing images, processing RAW photos and light editing. I’ve tried a number of Lightroom alternatives and while some of them are only ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

'ZDNET Recommends': What exactly does it mean? ZDNET's recommendations are based on many hours of testing, research, and comparison shopping. We gather data from the best available sources ...

So, with the TikTok ban still close — Apple and Google haven’t added the app back into app stores — what are the main alternatives? Here are the pros and cons of each when considering data ...

"JAECOO engineers have worked tirelessly to fine-tune Chery [Group]’s CDM hybrid technology to offer a truly viable alternative to a pure electric vehicle." The JAECOO 7 SHS powertrain features three ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato ... can outperform other standard alternatives for treatment-resistant depression ...